Up a level |
Pett, Sarah L, Spyer, Moira, Haddow, Lewis J, Nhema, Ruth, Benjamin, Laura A ORCID: 0000-0002-9685-1664, Najjuka, Grace, Bilima, Sithembile, Daud, Ibrahim, Musoro, Godfrey, Kitabalwa, Juliet et al (show 11 more authors)
(2021)
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
AIDS, 35 (4).
pp. 585-594.
Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Walker, A Sarah, Owen, Andrew ORCID: 0000-0002-9819-7651, Gibb, Diana M, Burger, David et al (show 2 more authors)
(2017)
Effect of diurnal variation, <i>CYP2B6</i> genotype and age on the pharmacokinetics of nevirapine in African children.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (1).
pp. 190-199.
Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Hoppe, Anne, Ndashimye, Emmanuel, Warambwa, Colin, Mambule, Ivan, van Oosterhout, Joep J, Wools-Kaloustian, Kara, Bertagnolio, Silvia et al (show 4 more authors)
(2017)
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 75 (2).
E45-E54.
Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey et al (show 7 more authors)
(2017)
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
The Lancet. Infectious diseases, 18 (1).
pp. 47-57.
Paton, Nicholas I, Kityo, Cissy, Thompson, Jennifer, Nankya, Immaculate, Bagenda, Leonard, Hoppe, Anne, Hakim, James, Kambugu, Andrew, van Oosterhout, Joep J, Kiconco, Mary et al (show 5 more authors)
(2017)
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
The lancet. HIV, 4 (8).
e341-e348.
Nkhata, Misheck J, Muzambi, Margaret, Ford, Deborah, Chan, Adrienne K, Abongomera, George, Namata, Harriet, Mambule, Ivan, South, Annabelle, Revill, Paul, Grundy, Caroline et al (show 11 more authors)
(2016)
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
BMC HEALTH SERVICES RESEARCH, 16 (1).
660-.
Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Owen, Andrew ORCID: 0000-0002-9819-7651, Walker, A Sarah, Gibb, DianaM et al (show 3 more authors)
(2016)
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 82 (1).
pp. 185-198.